Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01804530 | Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors | terminated | Phase 1 | 59 | PlexxikonINDUSTRY | 1 | Aug 2, 2018 | clinicaltrials |
| NCT02673736 | A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor | terminated | Phase 1 | 11 | PlexxikonINDUSTRY | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03415100 |
| Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours |
| unknown |
| Phase 1 |
| 30 |
| The Third Affiliated Hospital of Guangzhou Medical UniversityOTHER |
| 1 |
| Aug 1, 2018 |
| clinicaltrials |
| NCT01378377 | Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus | terminated | Phase 1 | 33 | EMD SeronoINDUSTRY | 1 | Jul 30, 2018 | clinicaltrials |
| NCT00445458 | A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | completed | Phase 1 / Phase 2 | 110 | Puma Biotechnology, Inc.INDUSTRY | 9 | Jul 26, 2018 | clinicaltrials |
| NCT01585701 | Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | completed | Phase 1 | 56 | Cancer Research UKOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02987504 | Study of Samalizumab in Patients With Advanced Cancer | terminated | Phase 1 | 10 | Alexion Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03326258 | Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 18, 2018 | clinicaltrials |
| NCT01705002 | Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors. | completed | Phase 1 | 88 | Lipomedix Pharmaceuticals Inc.INDUSTRY | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01246102 | AT13387 in Adults With Refractory Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01259479 | Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors | completed | Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02166255 | APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 17 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00892736 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | completed | Phase 1 | 98 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2018 | clinicaltrials |
| NCT00958724 | Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors | completed | Phase 1 | 6 | Puma Biotechnology, Inc.INDUSTRY | 1 | Jun 28, 2018 | clinicaltrials |
| NCT00074308 | Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers | completed | Phase 1 / Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2018 | clinicaltrials |
| NCT02439489 | Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | Fondazione MichelangeloOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT00878449 | A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer | completed | Phase 1 | 12 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01705106 | Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies | terminated | Phase 1 | 21 | University of ChicagoOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03529526 | Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 21 | Alphamab (Australia) Co Pty Ltd.INDUSTRY | 1 | May 22, 2018 | clinicaltrials |
| NCT00085553 | Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 29 | National Cancer Institute (NCI)NIH | 1 | May 18, 2018 | clinicaltrials |
| NCT01820299 | Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer | completed | Phase 1 | 22 | Medical University of South CarolinaOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT00522652 | Phase I Trial of PX-478 | completed | Phase 1 | 45 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT00726583 | Phase I Trial of Oral PX-866 | completed | Phase 1 | 90 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT00837928 | Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | completed | Phase 1 | 18 | John GreculaOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT01556789 | Phase 1 Study of ONT-10 in Patients With Solid Tumors | completed | Phase 1 | 85 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT01978964 | Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors | completed | Phase 1 | 90 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT02690350 | An Open Study Assessing the Safety and Tolerability of U3-1784 | terminated | Phase 1 | 10 | Daiichi SankyoINDUSTRY | 1 | May 16, 2018 | clinicaltrials |
| NCT02210663 | A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors | completed | Phase 1 | 16 | AbbVieINDUSTRY | 1 | May 7, 2018 | clinicaltrials |
| NCT03315091 | Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours | completed | Phase 1 | 31 | AstraZenecaINDUSTRY | 3 | Apr 30, 2018 | clinicaltrials |
| NCT00033215 | A Phase 1 Study of S-3304 in Patients With Solid Tumors | completed | Phase 1 | 32 | ShionogiINDUSTRY | 1 | Apr 26, 2018 | clinicaltrials |
| NCT02884479 | An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study | unknown | Phase 1 / Phase 2 | 75 | SciClone Pharmaceuticals International (Cayman) Development LimitedINDUSTRY | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | unknown | Phase 1 | 18 | SuZhou Stainwei Biotech Inc.INDUSTRY | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01762280 | A Phase I Study of Famitinib Malate in Patients With Solid Tumor | completed | Phase 1 | 55 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT00820768 | A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies | withdrawn | Phase 1 | 0 | CelgeneINDUSTRY | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT00290680 | Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | Medical University of South CarolinaOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT01875705 | A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 40 | Genentech, Inc.INDUSTRY | 2 | Apr 6, 2018 | clinicaltrials |
| NCT03448211 | A Study of PTS for Patients With Solid Tumors | withdrawn | Phase 1 | 0 | PTS International Inc.INDUSTRY | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00334789 | Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | completed | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2018 | clinicaltrials |
| NCT01654965 | Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2018 | clinicaltrials |
| NCT00014261 | Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT01275612 | Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers(CIS/MSC08) | withdrawn | Phase 1 | 0 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT01520389 | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | completed | Phase 1 | 112 | Merrimack PharmaceuticalsINDUSTRY | 1 | Mar 21, 2018 | clinicaltrials |
| NCT03472352 | Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors | unknown | Phase 1 | 15 | Hangzhou Converd Co., Ltd.INDUSTRY | 0 | Mar 21, 2018 | clinicaltrials |
| NCT02280954 | Indocyanine Green for Solid Tumors(818012) | completed | Phase 1 | 48 | University of PennsylvaniaOTHER | 1 | Mar 20, 2018 | clinicaltrials |
| NCT01470209 | A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies | completed | Phase 1 | 43 | Emory UniversityOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT01494688 | A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors | completed | Phase 1 | 217 | Hoffmann-La RocheINDUSTRY | 2 | Mar 16, 2018 | clinicaltrials |
| NCT03439761 | An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 125 | SciClone PharmaceuticalsINDUSTRY | 1 | Mar 16, 2018 | clinicaltrials |
| NCT02243917 | A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 62 | Cleave Biosciences, Inc.INDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Aug 2, 2018source: clinicaltrials